Sharekhan

Anlon Healthcare Ltd

Tue 17/02/2026,15:59:36 NSE: AHCL

₹ 121.60 1.32 (1.10%)
BUY NOW Buy Anlon Healthcare Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock Anlon Healthcare Ltd

Tue 17/02/2026,16:1:0

Anlon Healthcare Ltd

Tue 17/02/2026,15:59:36 | NSE : AHCL

₹ 121.601.32 (1.10%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 121.42

Previous Close

₹ 120.28

Volume

47882

Mkt Cap ( Rs. Cr)

₹646.32

High

₹ 123.24

Low

₹ 120.80

52 Week High

₹ 172.75

52 Week Low

₹ 90.78

Book Value Per Share

₹ 40.32

Dividend Yield

0.00

Face Value

₹ 10.00

What’s Your Call?

Collective community sentiment on Anlon Healthcare Ltd

Your Vote -

Buy

50.00%

Hold

0.00%

Sell

50.00%

50.00%

2 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

121.60

320

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

320

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Anlon Healthcare Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    13 Feb 2026, 12:44PM We have attached herewith Investor Earning Call Intimation As per regulation 30 of SEBI(LODR) Regulation, 2015

  • Anlon Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    13 Feb 2026, 12:36PM Anlon Healthcare Limited has informed the Exchange about Schedule of meet

  • Anlon Healthcare - Monitoring Agency Report

    12 Feb 2026, 11:35AM Anlon Healthcare Limited: Monitoring Agency Report for the quarter and Nine Months ended December 31, 2025

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Monitoring Agency Report

    12 Feb 2026, 11:39AM We have attached herewith Monitoring Agency Report for the quarter ended December 31, 2025.\r\n\r\nKindly take the same on your record.\r\n\r\nThank y

  • Anlon Healthcare - Copy of Newspaper Publication

    11 Feb 2026, 2:06PM Anlon Healthcare Limited has informed the Exchange about Copy of Newspaper Publication

  • Anlon Healthcare - Press Release

    10 Feb 2026, 12:18PM Anlon Healthcare Limited has informed the Exchange regarding a press release dated February 09, 2026, titled ""Intimation for Press release of Financi

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    10 Feb 2026, 12:22PM We have attached herewith Press Release as per Reg. 30 of SEBI (LODR) Regulation, 2015.\r\n\r\nKindly take the same on your record.\r\n\r\nThank you.

  • Anlon Healthcare - Appointment

    9 Feb 2026, 4:40PM Anlon Healthcare Limited has informed the Exchange regarding Appointment of Mr. Naimish Dilipbhai Bhatt as Chief Financial Officer of the company w.e

  • Anlon Healthcare - Resignation

    9 Feb 2026, 4:37PM Anlon Healthcare Limited has informed the Exchange regarding Resignation of Mr. Hitesh Bhavanjibhai Makwana as Chief Financial Officer of the company

  • Anlon Healthcare - Resignation

    9 Feb 2026, 4:33PM Anlon Healthcare Limited has informed the Exchange regarding Resignation of Mr. Shailesh Kantilal Thakkar as Non- Executive Independent Director of t

  • Anlon Healthcare - Appointment

    9 Feb 2026, 4:31PM Anlon Healthcare Limited has informed the Exchange regarding Appointment of Mr. Kishan Vinodkumar Raja as Non- Executive Independent Director of the

  • Anlon Healthcare - Updates

    9 Feb 2026, 4:28PM Anlon Healthcare Limited has informed the Exchange regarding 'Approved the Appointment of Mr. Naimish Dilipbhai Bhatt as a Chief FinancialOfficer (CFO

  • Anlon Healthcare - Updates

    9 Feb 2026, 4:25PM Anlon Healthcare Limited has informed the Exchange regarding 'Approved the resignation of Mr. Hitesh Bavanjibhai Makwana, Chief Financial Officer of t

  • Anlon Healthcare - Integrated Filing- Financial

    9 Feb 2026, 3:58PM We have attached herewith Financial Results for the quarter ended December 31, 2025.

  • Anlon Healthcare - Outcome of Board Meeting

    9 Feb 2026, 3:14PM Anlon Healthcare Limited has submitted to the Exchange, the financial results for the period ended December 31, 2025.

  • Anlon Healthcare - Approval Of Appointment Of Mr. Naimish Dilipbhai Bhatt As A Chief Financial Officer Of The Company.

    9 Feb 2026, 5:12PM We have attached herewith announcement as per Reg. 30 of SEBI (LODR) Regulation, 2015.\r\n\r\nKindly take the same on your record.\r\n\r\nThank you.

  • Anlon Healthcare - Approval Of Resignation Of Mr. Shailesh Kantilal Thakkar, Independent Director Of The Company.

    9 Feb 2026, 4:59PM We have attached herewith announcement as per SEBI (LODR) Regulations, 2015.\r\n\r\nKindly take the same on your record.\r\n\r\nThank you.

  • Anlon Healthcare - Appointment Of Mr. Kishan Vinodkumar Raja As A Independent Director

    9 Feb 2026, 4:55PM We have attached herewith announcement as per Reg. 30 of SEBI (LODR) Regulations, 2015.\r\n\r\nKindly take the same on your record.\r\n\r\nThank you.

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Resignation of Director

    9 Feb 2026, 4:47PM We have attached herewith announcement as per Reg. 30 of SEBI (LODR) Regulation, 2015.\r\n\r\nKindly take the same on your recorf.\r\n\r\nThank you.

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Resignation of Chief Financial Officer (CFO)

    9 Feb 2026, 4:43PM We have attached herewith announcement as per Reg. 30 of SEBI (LODR) Regulation, 2015.\r\n\r\nKindly take the same on your record.\r\n\r\nThank you.

  • Anlon Healthcare - Anlon Helthcare Limited_Financial Results For The Quarter Ended December 31, 2025

    9 Feb 2026, 4:10PM We have attached herewith Financial Results for the quarter ended December 31, 2025.\r\n\r\nKindly take the same on your record.\r\n\r\nThank you.

  • Anlon Healthcare - Board Meeting Outcome for Outcome Of Board Meeting For The Approval Of Financial Results For The Quarter E

    9 Feb 2026, 3:19PM We have attached herewith outcome of Board Meeting with other matters considered and approved.\r\n\r\nKindly take the same on your record.\r\n\r\nThan

  • Anlon Healthcare - The Company Has Purchased A Commercial Office At Ahmedabad, Gujarat And Shall Be Used For Marketing Office

    5 Feb 2026, 7:56PM We have attached herewith announcement as per Reg. 30 of SEBI (LODR) Regulation, 2015.\r\n\r\nKindly take the same on your record.\r\n\r\nThank you.

  • Anlon Healthcare - General Updates

    5 Feb 2026, 7:49PM Anlon Healthcare Limited has informed the Exchange about the Company has purchased a commercial office at Ahmedabad, Gujarat and shall be used for mar

  • Anlon Healthcare - Board Meeting Intimation for Consideration And Approve The Financial Results For The Quarter Ended Decembe

    3 Feb 2026, 7:13PM Anlon Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 09/02/2026 ,inter alia, to consider and

  • Anlon Healthcare - Updates

    28 Jan 2026, 2:04PM Anlon Healthcare Limited has informed the Exchange regarding 'Intimation as per Regulation 30 of Securities and Exchange Board of India (Listing Oblig

  • Anlon Healthcare - Intimation As Per Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclos

    28 Jan 2026, 2:08PM We have attached herewith intimation as per Regulation 30 of SEBI (LODR) Regulation, 2015.\r\n\r\nKindly take the same on your record.\r\n\r\nThank yo

  • Anlon Healthcare - Announcement With Continuation Of Our Earlier Intimation Dated December 02, 2025 Regarding The Execution O

    9 Jan 2026, 2:37PM We have attached herewith announcement as per Reg. 30 of SEBI (LODR) Regulation, 2015.\r\n\r\nKindly take the same on your record.\r\n\r\nThank you.

  • Anlon Healthcare - Updates

    9 Jan 2026, 2:33PM Anlon Healthcare Limited has informed the Exchange regarding 'continuation of our earlier intimation dated December 02, 2025 regarding the execution o

  • Anlon Healthcare - Shareholders meeting

    7 Jan 2026, 8:29PM Anlon Healthcare Limited has informed the Exchange regarding Proceedings of Postal Ballot. Further, the company has submitted the Exchange a copy of S

  • Anlon Healthcare - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    7 Jan 2026, 8:19PM We have attached herewith Scrutinizer's Report for postal ballot meeting.\r\n\r\nKindly take the same on your record.\r\n\r\nThank you.

  • Anlon Healthcare - Structural Digital Database

    7 Jan 2026, 3:24PM SDD Compliance certificate for the Quarter ended on December 31, 2025.

  • Anlon Healthcare - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    7 Jan 2026, 3:15PM Anlon Healthcare Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018 for the quarter ende

  • Anlon Healthcare has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2025

    7 Jan 2026, 3:30PM As of December 2025, 52.68% is owned by Indian Promoters and 47.32% by Public. <p align=justify> Institutional holds 4.72% (Insurance Companies 0.09%)

  • Anlon Healthcare - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    7 Jan 2026, 3:18PM We have attached herewith Certificate as per Reg. 74(5) of SEBI (DP) Regulation, 2018.\r\n\r\nKindly take the same on your record.\r\n\r\nThank you.

  • Anlon Healthcare - Trading Window

    29 Dec 2025, 9:46PM Anlon Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations,

  • Anlon Healthcare - Clarification - Financial Results

    23 Dec 2025, 5:46PM The Exchange has sought clarification from Anlon Healthcare Limited for the quarter ended 30-Jun-2025 with respect to Regulation 33 of the SEBI (Listi

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    23 Dec 2025, 4:43PM We have enclosed herewith announcement as per Reg. 30 of SEBI (LODR) Regulation, 2015.\r\n\r\nKindly take the same on your record. \r\n\r\nThank you.

  • Anlon Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    23 Dec 2025, 4:33PM Anlon Healthcare Limited has informed the Exchange about Schedule of meet

  • Anlon Healthcare - General Updates

    19 Dec 2025, 3:25PM Anlon Healthcare Limited has informed the Exchange about General Updates

  • Anlon Healthcare - Announcement As Per Reg. 30 Of SEBI (LODR) Regulation, 2015

    19 Dec 2025, 3:22PM We have attached herewith announcement as per Reg. 30 of SEBI (LODR) Regulation, 2015 for planning to opening a marketing office at Ahmadabad, Gujarat

  • Anlon Healthcare - Results-Delay in Financial Results

    18 Dec 2025, 4:44PM Respected Sir/Madam,\r\n\r\nWe have attached herewith Financial Results for the quarter ended on June 30, 2025.\r\n\r\nKindly take the same on your re

  • Anlon Healthcare - Copy of Newspaper Publication

    9 Dec 2025, 2:40PM Anlon Healthcare Limited has informed the Exchange about Copy of Newspaper Publication

  • Anlon Healthcare - Shareholder Meeting / Postal Ballot-Notice of Postal Ballot

    8 Dec 2025, 7:49PM We have attached herewith Intimation of Postal Ballot Notice.\r\n\r\nKindly take the same on your record.\r\n\r\nThank you.\r\n\r\n\r\n\r\n

  • Anlon Healthcare - Shareholders meeting

    8 Dec 2025, 7:42PM Anlon Healthcare Limited has informed the Exchange regarding Notice of undefined to be held on January 07, 2026

  • Anlon Healthcare - Board Meeting Outcome for Held On Friday, December 05, 2025

    5 Dec 2025, 2:38PM We have attached herewith Outcome of Board Meeting held on Friday, December 05, 2025.\r\n\r\nKindly take the same on your record.\r\n\r\nThank you.

  • Anlon Healthcare - Outcome of Board Meeting

    5 Dec 2025, 2:36PM Anlon Healthcare Limited has informed the Exchange regarding Outcome of Board Meeting held on December 05, 2025.

  • Anlon Healthcare - Others

    2 Dec 2025, 1:26PM With reference to the captioned subject, we would like to inform you that company has entered into a Share Purchase Agreement ( SPA ) with Apiqo Organ

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements

    2 Dec 2025, 1:33PM We have attached herewith announcement as per Reg. 30 of SEBI (LODR) Regulation, 2015 for Share Purchase Agreement executed between the Anlon Healthca

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements

    28 Nov 2025, 5:41PM We have attached herewith announcement as per Reg. 30 of SEBI (LODR) Regulation, 2015 for Share Purchase Agreement executed between the Anlon Healthca

  • Anlon Healthcare - Others

    28 Nov 2025, 5:30PM With reference to the captioned subject, we would like to inform you that company has entered into a Share Purchase Agreement ( SPA ) with Bizotic Lif

  • Anlon Healthcare - Updates

    28 Nov 2025, 4:45PM The earlier copy of financial results was not in machine readable form. We have attached herewith revised copy in Machine readable form.

  • Anlon Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    25 Nov 2025, 5:24PM Anlon Healthcare Limited has informed the Exchange about Schedule of meet

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    25 Nov 2025, 5:31PM We have attached herewith Intimation regarding Investor (s)/Analyst (s) meet.\r\n\r\nKindly take the same on your record.\r\n\r\nThank you.\r\n\r\n

  • Anlon Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    24 Nov 2025, 5:00PM Anlon Healthcare Limited has informed the Exchange about Transcript

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    24 Nov 2025, 5:13PM We have attached herewith Earning Call Transcript as per Reg. 30 (LODR), Regulations, 2015.\r\n\r\nKindly take same on your records.\r\n\r\nThanking Y

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    19 Nov 2025, 7:45PM We have attached herewith Outcome with call recording of Earning Conference Call with Multiple Investor(s) or Analyst (s).\r\n\r\nKindly take the same

  • Anlon Healthcare - Analysts/Institutional Investor Meet/Con. Call Updates

    19 Nov 2025, 7:37PM Anlon Healthcare Limited has informed the Exchange about Link of Recording

  • Anlon Healthcare - Investor Presentation

    19 Nov 2025, 10:11AM Anlon Healthcare Limited has informed the Exchange about Investor Presentation

  • Anlon Healthcare - Announcement under Regulation 30 (LODR)-Investor Presentation

    19 Nov 2025, 10:15AM We have attached herewith Investor Presentation.\r\n\r\nKindly take the same on your record.\r\n\r\nThank you.
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Anlon Healthcare Ltd stock 

Name March-25 March-24 March-23
Assets 138.7691 95.5946 73.761
Liabilities 138.7691 95.5946 73.761
Equity 39.8515 16 12
Gross Profit 32.2087 15.4611 12.4148
Net Profit 20.5179 9.6571 5.82
Cash From Operating Activities -22.5517 -3.226 -2.8497
NPM(%) 17.05 14.5 5.15
Revenue 120.2866 66.5837 112.8774
Expenses 88.0779 51.1226 100.4626
ROE(%) 9.57 4.5 2.71

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Anlon Healthcare Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 734.25 -0.23 43.60 68.57 301.39 0.68
Lotus Eye Hospital and Institute Ltd 124.00 4.44 400.00 249.87 3.55 0.00
Vaishali Pharma Ltd 7.92 -1.74 0.00 1567.50 3.13 0.00
Astec Lifesciences Ltd 642.60 3.12 0.00 235.63 -604.77 0.00

Company Info

Our Company was originally incorporated as 'Anlon Ventures Private Limited', a private limited company under the erstwhile Companies Act, 1956, pursuant to a certificate of incorporation dated November 19, 2013 issued by the RoC. The name of our Company was changed from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited' and a fresh certificate of incorporation dated May 27, 2015 was issued by the RoC pursuant to the approval of the Board on May 1, 2015 and the Shareholders on May 5, 2015. Our Company was subsequently converted to a public limited company and the name of our Company was changed from 'Anlon Healthcare Private Limited' to 'Anlon Healthcare Limited' pursruant to the approval of the Board dated July 8, 2024 and Shareholders August 3, 2024 and a fresh certificate of incorporation dated September 2, 2024 was issued by the RoC.Our Company was incorporated in the year 2013 as 'Anlon Ventures Private Limited'. In the year 2015, our Company changed its name to Anlon Healthcare Private Limited and decided to establish its own manufacturing facility for manufacturing of pharmaceutical intermediates and APIs. Following this decision, our company began the process of land procurement, construction, and installation of plant and machinery, which were completed in the year 2017. Year 2017 onwards, we started our trial production of pharma intermediates and APIs.Major Events and Milestones:2013- Incorporated as 'Anlon Ventures Private Limited'2015- Change of name from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited'.2017- Received ISO 9001:2015 certification2018- Commenced commercial Production of Pharma Intermediate and API2018- Made our first export of our product to South Korea2019- Received Good Manufacturing Practice certification for our Manufacturing Facility- Received accreditation of Foreign Manufacturer from Pharmaceuticals and Medical Devices Agency, Japan2021- Received Good Manufacturing Practice - World Health Organization Certification for our Manufacturing Facility2024- Received approval for Drug Master File from Brazilian Health Regulatory Agency for our API product namely, loxoprofen sodium dihydrate- Conversion of our Company from private limited to public limited and the consequent change of name from 'Anlon Healthcare Private Limited' to 'Anlon Healthcare Limited'.2025-The Company has entered into a Share Purchase Agreement between the Anlon Healthcare Limited and Apiqo Organics Private Limited.

Our Company was originally incorporated as 'Anlon Ventures Private Limited', a private limited company under the erstwhile Companies Act, 1956, pursuant to a certificate of incorporation dated November 19, 2013 issued by the RoC. The name of our Company was changed from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited' and a fresh certificate of incorporation dated May 27, 2015 was issued by the RoC pursuant to the approval of the Board on May 1, 2015 and the Shareholders on May 5, 2015. Our Company was subsequently converted to a public limited company and the name of our Company was changed from 'Anlon Healthcare Private Limited' to 'Anlon Healthcare Limited' pursruant to the approval of the Board dated July 8, 2024 and Shareholders August 3, 2024 and a fresh certificate of incorporation dated September 2, 2024 was issued by the RoC.Our Company was incorporated in the year 2013 as 'Anlon Ventures Private Limited'. In the year 2015, our Company changed its name to Anlon Healthcare Private Limited and decided to establish its own manufacturing facility for manufacturing of pharmaceutical intermediates and APIs. Following this decision, our company began the process of land procurement, construction, and installation of plant and machinery, which were completed in the year 2017. Year 2017 onwards, we started our trial production of pharma intermediates and APIs.Major Events and Milestones:2013- Incorporated as 'Anlon Ventures Private Limited'2015- Change of name from 'Anlon Ventures Private Limited' to 'Anlon Healthcare Private Limited'.2017- Received ISO 9001:2015 certification2018- Commenced commercial Production of Pharma Intermediate and API2018- Made our first export of our product to South Korea2019- Received Good Manufacturing Practice certification for our Manufacturing Facility- Received accreditation of Foreign Manufacturer from Pharmaceuticals and Medical Devices Agency, Japan2021- Received Good Manufacturing Practice - World Health Organization Certification for our Manufacturing Facility2024- Received approval for Drug Master File from Brazilian Health Regulatory Agency for our API product namely, loxoprofen sodium dihydrate- Conversion of our Company from private limited to public limited and the consequent change of name from 'Anlon Healthcare Private Limited' to 'Anlon Healthcare Limited'.2025-The Company has entered into a Share Purchase Agreement between the Anlon Healthcare Limited and Apiqo Organics Private Limited.

Read More

Parent Organisation

Anlon Healthcare Ltd.

Founded

19/11/2013

Managing Director

Mr.Punitkumar R Rasadia

NSE Symbol

AHCLEQ

FAQ

The current price of Anlon Healthcare Ltd is ₹ 121.60.

The 52-week high for Anlon Healthcare Ltd is ₹ 123.24 and the 52-week low is ₹ 120.80.

The market capitalization of Anlon Healthcare Ltd is currently ₹ 646.32. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy Anlon Healthcare Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in Anlon Healthcare Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase Anlon Healthcare Ltd shares.

The CEO of Anlon Healthcare Ltd is Mr.Punitkumar R Rasadia, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT